Ribomic Inc. (TYO:4591)
55.00
-1.00 (-1.79%)
Nov 18, 2026, 11:22 AM JST
Ribomic Market Cap
Ribomic has a market cap or net worth of 3.12 billion as of November 17, 2026. It is the 36,642nd most valuable company in the world and the 3,384th biggest in Japan. Its market cap has decreased by 27.55% in one year.
Market Cap
3.12B
Enterprise Value
628.48M
Revenue
19.00M
Global Rank
Country Rank
#3,384 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 25, 2014, Ribomic's market cap has decreased from 22.97B to 3.12B, a decrease of -86.40%. That is a compound annual growth rate of -15.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 3.12B | -24.15% |
| Dec 30, 2025 | 4.12B | 20.26% |
| Dec 30, 2024 | 3.43B | -11.13% |
| Dec 29, 2023 | 3.85B | -41.00% |
| Dec 30, 2022 | 6.53B | -43.16% |
| Dec 30, 2021 | 11.49B | 13.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kringle Pharma | 4.81B |
| MEDINET | 4.27B |
| SUSMED,Inc. | 4.19B |
| Noile-Immune Biotech | 3.47B |
| Chordia Therapeutics | 3.33B |
| Modalis Therapeutics | 3.18B |
| PRISM BioLab Co.,LTD | 3.18B |
| Kohjin Bio | 3.17B |